Bjoern Traenkle

PET-based immunomapping of intratumoral CD4 ⁺ cells to monitor acquired resistance to checkpoint inhibitors

Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells

Longitudinal Analysis of Humoral and Cellular Immunity in SARS-CoV-2 Exposed Families

A Novel PNGase Rc for Improved Protein N-Deglycosylation in Bioanalytics and Hydrogen–Deuterium Exchange Coupled With Mass Spectrometry Epitope Mapping under Challenging Conditions

Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

NeutrobodyPlex—monitoring SARS-CoV-2 neutralizing immune responses using nanobodies

Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors

Single-domain antibodies for targeting, detection and <i>in vivo</i> imaging of human CD4 ⁺ cells

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens

NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response